However, despite our experimental study showing the beneficial effects of the IL-6 pathway blockade on acute stroke, to be more closely related to clinical practice, a design with an IL-6-blockade with different administration time points (e.g., after acute insults) is necessary to elucidate its effect on stroke-induced inflammatory and metabolic responses. This evidence concerns the gene IL6 and Stroke.